| Focus on therapy of hypnic headache. | |
| | |
MedLine Citation:
|
PMID: 20585827 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Hypnic headache (HH) is a primary headache disorder, which occurs exclusively during sleep and usually begins after 50 years of age. There are no controlled trials for the treatment of HH. We reviewed all the available papers, including 119 cases published in literature up to date, reporting the efficacy of the medications used to treat HH. Acute treatment is not recommended, since no drug proved to be clearly effective and also because the intensity and the duration of the attacks do not require the intake of a medication in most cases. As for prevention, a wide variety of medications were reported to be of benefit in HH. The drugs that were found to be effective in at least five cases are: lithium, indomethacin, caffeine and flunarizine. Lithium was the most extensively studied compound and demonstrated to be an efficacious treatment in 32 cases. Unfortunately, despite its efficacy, significant adverse effects and poor tolerability are not rare, mainly in elderly patients. Many patients reported a good response to indomethacin, but some could not tolerate it. Caffeine and melatonin treatments did not yield robust evidence to recommend their use as single preventive agents. Nevertheless, their association with lithium or indomethacin seems to produce an additional therapeutic efficacy. A course of lithium should be tried first, followed 3-4 months later by tapering. If headache recurs during tapering, a longer duration of therapy may be needed. If lithium treatment does not provide a significant response, indomethacin can be commenced as second-line approach. If these treatments prove to be ineffective or poorly tolerated, other agents, such as caffeine and melatonin, can be administered. |
| | |
Authors:
|
Carlo Lisotto; Paolo Rossi; Cristina Tassorelli; Enrico Ferrante; Giuseppe Nappi |
Related Documents
:
|
1154017 - An investigation into the use of anafranil in phobic and obsessional disorders. 12609397 - Topiramate overdose: a case report and literature review. 17347127 - Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neuro... 19917737 - The effect of heel height on gait and posture: a review of the literature. 15261167 - Review of nonablative laser resurfacing modalities. 1770927 - Trichinosis surveillance, united states, 1987-1990. |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-06-29 |
Journal Detail:
|
Title: The journal of headache and pain Volume: 11 ISSN: 1129-2377 ISO Abbreviation: J Headache Pain Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-08-09 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100940562 Medline TA: J Headache Pain Country: Italy |
Other Details:
|
Languages: eng Pagination: 349-54 Citation Subset: IM |
Affiliation:
|
Headache Centre, Department of Neuroscience, S. Vito al Tagliamento Hospital, Pordenone, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: STin2 VNTR polymorphism in the serotonin transporter gene and migraine: pooled and meta-analyses.
Next Document: Population structure of Nouelia insignis (Asteraceae), an endangered species in southwestern China, ...